Search Results - "Balestrini, Juri"
-
1
Dual Effect of PER2 C111G Polymorphism on Cognitive Functions across Progression from Subjective Cognitive Decline to Mild Cognitive Impairment
Published in Diagnostics (Basel) (18-04-2021)“…Periodic circadian protein homolog 2 ( ) has a role in the intracellular signaling pathways of long-term potentiation and has implications for synaptic…”
Get full text
Journal Article -
2
Subjective cognitive decline: 15 years of follow-up experience from a memory clinic (P7-6.005)
Published in Neurology (25-04-2023)“…Abstract only…”
Get full text
Journal Article -
3
Plasma neurofilament light chain predicts Alzheimer's disease in patients with subjective cognitive decline and mild cognitive impairment: A cross‐sectional and longitudinal study
Published in European journal of neurology (01-01-2024)“…Background and purpose We aimed to evaluate the accuracy of plasma neurofilament light chain (NfL) in predicting Alzheimer's disease (AD) and the progression…”
Get full text
Journal Article -
4
Huntingtin gene intermediate alleles influence the progression from subjective cognitive decline to mild cognitive impairment: A 14‐year follow‐up study
Published in European journal of neurology (01-06-2022)“…Background and purpose Huntingtin (HTT) is a gene containing a key region of CAG repeats. HTT alleles containing from 27 to 35 CAG repeats are termed…”
Get full text
Journal Article -
5
Data-driven subtypes of mixed semantic-logopenic primary progressive aphasia: Linguistic features, biomarker profiles and brain metabolic patterns
Published in Journal of the neurological sciences (15-05-2024)“…Mixed primary progressive aphasia (mPPA) accounts for a substantial proportion of primary progressive aphasia (PPA) cases. However, the lack of a standardised…”
Get full text
Journal Article -
6
The role of plasma neurofilament light chain and glial fibrillary acidic protein in subjective cognitive decline and mild cognitive impairment
Published in Neurological sciences (01-03-2024)“… Introduction and aim NfL and GFAP are promising blood-based biomarkers for Alzheimer's disease. However, few studies have explored plasma GFAP in the…”
Get full text
Journal Article -
7
Plasma neurofilament light chain predicts Alzheimer’s disease in patients with subjective cognitive decline and mild cognitive impairment: a longitudinal study
Published in Alzheimer's & dementia (01-12-2023)“…Background Subjective cognitive decline (SCD) and mild cognitive impairment (MCI) represent a target population for early detection of Alzheimer’s Disease…”
Get full text
Journal Article -
8
A machine learning model to predict progression from subjective cognitive decline to mild cognitive impairment and dementia: a 12‐year follow‐up study
Published in Alzheimer's & dementia (01-12-2023)“…Background Subjective cognitive decline (SCD) represents a target population to be screened for dementia. Previous studies identified demographic, cognitive…”
Get full text
Journal Article -
9
Influence of ApoE Genotype and Clock T3111C Interaction with Cardiovascular Risk Factors on the Progression to Alzheimer’s Disease in Subjective Cognitive Decline and Mild Cognitive Impairment Patients
Published in Journal of personalized medicine (29-05-2020)“…Background: Some genes could interact with cardiovascular risk factors in the development of Alzheimer’s disease. We aimed to evaluate the interaction between…”
Get full text
Journal Article -
10
Matching Clinical Diagnosis and Amyloid Biomarkers in Alzheimer's Disease and Frontotemporal Dementia
Published in Journal of personalized medicine (14-01-2021)“…The aims of this study were to compare the diagnostic accuracy, sensitivity, specificity, and positive and negative predictive values (PPV, NPV) of different…”
Get full text
Journal Article -
11
Alzheimer’s Disease CSF Biomarker Profiles in Idiopathic Normal Pressure Hydrocephalus
Published in Journal of personalized medicine (06-06-2022)“…Patients with idiopathic normal pressure hydrocephalus (iNPH) frequently show pathologic CSF Aβ42 levels, comparable with Alzheimer’s Disease (AD)…”
Get full text
Journal Article